Abstract:Objective:To explore the potential serum biomarkers of patients with lupus nephritis(LN)by using two-dimensional electrophoresis combined with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry(MALDI-TOF/TOF MS),so as to lay the foundation for illuminating pathogenesis.Methods:A total of 40 LN patients were divided into two groups,the active LN group and the inactive LN group,with 20 in each.In addition,20 IgA nephritis patients and 20 healthy volunteers were enrolled as IgAN group and healthy control group.Two-dimensional gel electrophoresis was used to separate and analyze the serum proteins,and MALDI-TOF/TOF MS was applied to the identification of the differentially expressed pro-teins.Results:A total of fifty differentially expressed proteins were identified.Compared with that in healthy control group,23 differentially expressed proteins were discovered in active LN group and inactive LN group,among which,8 proteins were up-regulated and 1 5 proteins were down-regulated.And 1 8 differentially expressed proteins,compared with IgA nephritis group, were found in active LN group and inactive LN group,including 13 up-regulated proteins and 5 down-regulated proteins.Fur-thermore,the number of up-regulated and down-regulated proteins in active LN group,compared with those in inactive LN group,were 4 and 5,respectively.Among the 50 identified differentially expressed proteins,the expression of serum amyloid protein A(SAA )in active LN group was higher than that in the other groups while the expression of complement component C4A in active LN group was lower than that in the other groups.And the expression of chain B (solution structure of double super helix model)in the inactive LN group was higher than that in the other groups.Compared with that in healthy control group,the expression of vitamin D-binding protein isoform 1 precursor,chain A(crystal structure of uncomplexed vitamin D-binding protein)and chain B (a covalent dimer of transthyretin that affects the amyloid pathway)was up-regulated in both ac-tive LN group and inactive LN group,while the expression of the vitronectin precursor,ficolin-2 isoform a precursor and chain A (crystal structure of the catalytic domain of human complement C1 s protease)was down-regulated.Compared with that in IgA nephritis group,the expression of lipoprotein CIII and vitronectin precursor was up-regulated in both active LN group and inactive LN group.Conclusions:Combination of two-dimensional gel electrophoresis and MALDI-TOF/TOF MS is effective for screening and identification of differentially expressed proteins in serum from LN patients.These differentially expressed pro-teins could be used as biomarkers for noninvasive diagnosis and evaluation of LN.Further study on these proteins would be conducive to understanding the pathogenesis of LN.

The screen of serum microRNA in Ⅳand Ⅳ+Ⅴ lupus nephritis patients

Clinical Significance of Serum miR-4762-5p in Differentiating between Class Ⅳ and Class Ⅳ+Ⅴ Lupus Nephritis

THU0247 LRRN4: A NOVEL PROGNOSTIC BIOMARKER OF RENAL OUTCOME IN LUPUS NEPHRITIS PATIENTS

Analysis of Microrna-199A-3p Expression in CD4 + T Cells of Systemic Lupus Erythematosus

Circulating exosomal microRNAs as biomarkers of lupus nephritis

Early-stage predictors for treatment responses in patients with active lupus nephritis.

Novel Long Non-coding RNA Expression Profile of Peripheral Blood Mononuclear Cells Reveals Potential Biomarkers and Regulatory Mechanisms in Systemic Lupus Erythematosus

Tissue-Specific Microrna Expression Patterns in Four Types of Kidney Disease

Novel Microrna Biomarkers of Systemic Lupus Erythematosus in Plasma: Mir-124-3p and Mir-377-3p.

LncRNA XIST/miR-381-3P/STAT1 axis as a potential biomarker for lupus nephritis

Study of MicroRNA-124 in Patients with Lupus Nephritis

Expression of microRNA on peripheral blood cells in patients with systemic lupus erythematosus

Identification and Validation of IFI44 As Key Biomarker in Lupus Nephritis.

Predicting diagnostic gene expression profiles associated with immune infiltration in patients with lupus nephritis

Exploring Serum Protein Biomarkers of Lupus Nephritis by Using Two-Dimensional Gel Electrophoresis Com-bined with Matrix-Assisted Laser Desorption/Ionization Time of Flight Mass Spectrometry

Detection of miRNA in kidney biopsies of child patients with nephrotic syndrome and its significance

Identification of macrophage-related candidate genes in lupus nephritis using bioinformatics analysis

Differentially Expressed Micrornas in Kidney Biopsies from Various Subtypes of Nephrotic Children.

Exploring the Differences in Molecular Mechanisms and Key Biomarkers Between Membranous Nephropathy and Lupus Nephritis Using Integrated Bioinformatics Analysis

Integrative analysis of COL6A3 in lupus nephritis: insights from single-cell transcriptomics and proteomics

Applying 12 machine learning algorithms and Non-negative Matrix Factorization for robust prediction of lupus nephritis